Quizartinib for Newly Diagnosed <i>FLT3</i> -Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study

Pau Montesinos, Jorge Labrador, Juan Bergua et al.|Journal of Clinical Oncology|2025

Cited by 13